Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

KNSANASDAQ • USD
95.28 USD
↘ 1.05 (1.09%)🟢LIVE (AS OF 12:28 PM EST)
🟢Market: OPEN

Shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) are trading at $95.28. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$96.67
High?$97.83
Low?$94.04
Prev. Close?$96.33
Volume?113.3K
Avg. Volume?822.1K
VWAP?$96.07
Rel. Volume?0.14x
Bid / Ask
Bid?$81.37 × 100
Ask?$95.69 × 100
Spread?$14.32
Midpoint?$88.53
Valuation & Ratios
Market Cap?7.6B
Shares Out?48.8M
Float?39.2M
Float %?81.1%
P/E Ratio?69.08
P/B Ratio?10.66
EPS?$1.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Employees
366
Market Cap
7.6B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-05-24
Address
105 PICCADILLY, SECOND FLOOR
LONDON, W1J 7NJ
Phone: (781) 431-9100
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
100
Momentum?
94
Short Sent.?
55
Piotroski F-Score?5/9Mixed
Altman Z-Score?18.19Safe
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.96%High
Short Interest?4.3M
Days to Cover?3.9
Free Float39.2M
Avg Daily Volume1.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.91Strong
Quick Ratio?3.35Strong
Cash Ratio?0.43Low
Debt/Equity?0.15Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
33/100
P/E?
Peers
100
S&P
7
69.1PRICEY▾
P/B?
Peers
100
S&P
18
10.66HIGH▾
P/S?
Peers
100
S&P
13
8.00HIGH▾
P/FCF?
Peers
100
S&P
18
38.4PRICEY▾
EV/EBITDA?
Peers
100
S&P
3
57.4HIGH▾
EV/Sales?
Peers
100
S&P
17
8.03HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
55
15.4%STRONG▾
ROA?
Peers
50
S&P
78
11.1%STRONG▾
Cash Flow & Enterprise
FCF?$197.2M
Enterprise Value?$7.6B
Fundamentals ratios updated end of day